Hypothesis and Theory
Published on 18 May 2017
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
in Alloimmunity and Transplantation
- 46,403 views
- 282 citations